🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Purpose: To develop a real time national clinical database to support and ...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00371774
The objective of this study is to compare the pharmacokinetic and pharmacod...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00653822
Alefacept (AMEVIVE®) is an immunosuppressive dimeric fusion protein that co...
Status
Completed
Location
Department of Stem cell Transplantation & Cancer immunotherapy; Cell Therapy & Transplantation Biology Research Laboratory, Hadassah University Hospital
Start Date
2006-10
Trial ID
NCT00397332
Treatments Being Tested
Comparison of two dosing regimens of Alefacept in subjects weighing between...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00674063
Treatments Being Tested
The purpose of this study is to find out how safe and effective an investig...
Status
Terminated
Location
Clinical Unit for Research Trials in Skin
Start Date
2004-04
Trial ID
NCT00135733
Treatments Being Tested
The purpose of this study is to determine whether the biologic medication a...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2008-12
Trial ID
NCT00815633
Treatments Being Tested
An extension study to evaluate safety and tolerability of up to 3 additiona...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00692172
Treatments Being Tested
The purpose of this study is to determine whether repeat courses of aleface...
Status
Completed
Location
University of California, Irvine
Start Date
2002-12-01
Trial ID
NCT00233662
Treatments Being Tested
To establish the safety of alefacept when administered to adolescent subjec...
Status
Completed
Location
Pediatric and Adolescent Dermatology
Start Date
2009-04
Trial ID
NCT00808223
Treatments Being Tested
Alefacept is a drug tht may reduce the number of T cells in circulation. Th...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2010-10
Trial ID
NCT01226420
Treatments Being Tested